Acutus Medical (AFIB)
(Delayed Data from NSDQ)
$0.17 USD
0.00 (-2.58%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $0.17 0.00 (0.00%) 7:24 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
AFIB 0.17 0.00(-2.58%)
Will AFIB be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for AFIB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AFIB
Acutus Medical, Inc. (AFIB) Reports Q2 Loss, Tops Revenue Estimates
USANA Health Sciences (USNA) Tops Q2 Earnings and Revenue Estimates
AFIB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Acutus Medical, Inc. (AFIB) Q4 Earnings and Revenues Surpass Estimates
Acutus Medical, Inc. (AFIB) Reports Q3 Loss, Tops Revenue Estimates
Lyell Immunopharma (LYEL) Reports Q3 Loss, Lags Revenue Estimates
Other News for AFIB
12 Health Care Stocks Moving In Wednesday's After-Market Session
Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results
Acutus Medical GAAP EPS of -$2.81, revenue of $7.2M
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
12 Health Care Stocks Moving In Tuesday's Intraday Session